ResMed (RMD) : Tuesdays money flow indicated an uptick to downtick ratio was at 1.61. The total value of inflow transactions on upticks was $9.78 million, whereas, the total value of outflow trades on downticks was $6.06 million. The total money flow was $3.72 million, which shows a mild bullish bias. The total money flow into the stock in block trades was $2.96 million. The total value of the trades done on upticks was $2.96 million. ResMed (RMD) was trading with a -0.4% change over previous days close. It fell $0.26 during the day and reached $64.02. The stock was -0.76% compared to the previous weeks close.
The company Insiders own 2.54% of ResMed shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -9.31% . Institutional Investors own 58.7% of ResMed shares. During last six month period, the net percent change held by insiders has seen a change of -14.52%. In an insider trading activity, The director, of Resmed Inc, Farrell Peter C had unloaded 20,000 shares at $63.62 per share in a transaction on July 7, 2016. The total value of transaction was $1,272,400. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Shares of ResMed Inc. rose by 0.66% in the last five trading days and 7.06% for the last 4 weeks. ResMed Inc. is up 8.32% in the last 3-month period. Year-to-Date the stock performance stands at 20.49%.
ResMed (NYSE:RMD): On Tuesdays trading session , Opening price of the stock was $64.28 with an intraday high of $64.57. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $63.85. However, the stock managed to close at $64.02, a loss of 0.40% for the day. On the previous day, the stock had closed at $64.28. The total traded volume of the day was 675,191 shares.
ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.